{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:26:39Z","timestamp":1762507599318,"version":"3.37.3"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.humpath.2018.12.003","type":"journal-article","created":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T03:13:17Z","timestamp":1545880397000},"page":"182-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The presence of Y674\/Y675 phosphorylated NTRK1 via TP53 repression of PTPN6 expression as a potential prognostic marker in neuroblastoma"],"prefix":"10.1016","volume":"86","author":[{"given":"Gehad","family":"Youssef","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dyanne","family":"Rampling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasnim","family":"Chagtai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Virasami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Barton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darren","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Sebire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ximena","family":"Montano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2018.12.003_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.24659","article-title":"The \"neuro\" of neuroblastoma: neuroblastoma as a neurodevelopmental disorder","volume":"80","author":"Ratner","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.humpath.2018.12.003_bb0010","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2014.59.4648","article-title":"Advances in risk classification and treatment strategies for neuroblastoma","volume":"33","author":"Pinto","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2018.12.003_bb0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/pbc.23343","article-title":"Clinical significance of NTRK family gene expression in neuroblastomas","volume":"59","author":"Light","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.humpath.2018.12.003_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12688\/f1000research.8434.1","article-title":"Recent advances in understanding neurotrophin signaling","volume":"5","author":"Bothwell","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.humpath.2018.12.003_bb0025","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/pbc.25934","article-title":"Segmental chromosomal aberrations in localized neuroblastoma can be detected in formalin-fixed paraffin-embedded tissue samples and are associated with recurrence","volume":"63","author":"Pinto","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.humpath.2018.12.003_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00383-012-3239-7","article-title":"The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis","volume":"29","author":"Domingo-Fernandez","year":"2013","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.humpath.2018.12.003_bb0035","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.2007.14.5839","article-title":"Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience","volume":"27","author":"Canete","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2018.12.003_bb0040","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1128\/MCB.25.9.3737-3751.2005","article-title":"Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2\/M promoters","volume":"25","author":"Imbriano","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2018.12.003_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/cdd.2017.171","article-title":"Deconstructing networks of p53-mediated tumor suppression in vivo","volume":"25","author":"Kaiser","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.humpath.2018.12.003_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a026179","article-title":"Somatic TP53 mutations in the era of genome sequencing","volume":"6","author":"Hainaut","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.humpath.2018.12.003_bb0055","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.febslet.2014.04.015","article-title":"The cytoplasmic side of p53's oncosuppressive activities","volume":"588","author":"Comel","year":"2014","journal-title":"FEBS Lett"},{"key":"10.1016\/j.humpath.2018.12.003_bb0060","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygeno.2013.10.001","article-title":"Characterization of SHP-1 protein tyrosine phosphatase transcripts, protein isoforms and phosphatase activity in epithelial cancer cells","volume":"102","author":"Evren","year":"2013","journal-title":"Genomics"},{"key":"10.1016\/j.humpath.2018.12.003_bb0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/187152011794941154","article-title":"SHP-1 in cell-cycle regulation","volume":"11","author":"L\u00f3pez-Ruiz","year":"2011","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.humpath.2018.12.003_bb0070","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1083\/jcb.200309036","article-title":"SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase","volume":"163","author":"Marsh","year":"2003","journal-title":"J Cell Biol"},{"key":"10.1016\/j.humpath.2018.12.003_bb0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.onc.1201215","article-title":"P53 associates with trk tyrosine kinase","volume":"15","author":"Montano","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2018.12.003_bb0080","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1038\/sj.onc.1203619","article-title":"C-abl is involved in the association of p53 and trk a","volume":"19","author":"Brown","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2018.12.003_bb0085","first-page":"4337","article-title":"Expression of nerve growth factor receptors and their prognostic value in human breast cancer","volume":"61","author":"Descamps","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2018.12.003_bb0090","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1038\/onc.2009.143","article-title":"Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation","volume":"28","author":"Montano","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2018.12.003_bb0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/modpathol.2013.129","article-title":"Phosphorylation of NTRK1 at Y674\/Y675 induced by TP53-dependent repression of PTPN6 expression: a potential novel prognostic marker for breast cancer","volume":"27","author":"Youssef","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2018.12.003_bb0100","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group","volume":"103","author":"Dowsett","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.humpath.2018.12.003_bb0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/jclinpath-2012-201091","article-title":"Translational subgroup of the NBCSG. The manufacture and assessment of tissue microarrays: suggestions and criteria for analysis, with breast cancer as an example","volume":"66","author":"Pinder","year":"2013","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2018.12.003_bb0110","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/pbc.24777","article-title":"Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project","volume":"61","author":"Mosse","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.humpath.2018.12.003_bb0115","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/bjc.2012.375","article-title":"Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project","volume":"107","author":"Schleiermacher","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2018.12.003_bb0120","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1016\/S0959-8049(97)00210-4","article-title":"Monoclonal antibody to human Trk-A: diagnostic and therapeutic potential in neuroblastoma","volume":"33","author":"Kramer","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2018.12.003_bb0125","doi-asserted-by":"crossref","first-page":"15495","DOI":"10.1523\/JNEUROSCI.5599-11.2012","article-title":"Trk activation of the ERK1\/2 kinase pathway stimulates intermediate chain phosphorylation and recruits cytoplasmic dynein to signaling endosomes for retrograde axonal transport","volume":"32","author":"Mitchell","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.humpath.2018.12.003_bb0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12253-008-9065-5","article-title":"Significance of SHP-1 and SHP2 expression in human papillomavirus infected Condyloma acuminatum and cervical cancer","volume":"14","author":"Tao","year":"2008","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.humpath.2018.12.003_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01611179","article-title":"Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas","volume":"421","author":"Soini","year":"1992","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.humpath.2018.12.003_bb0140","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.4161\/cc.6.21.4853","article-title":"p53 is nuclear and functional in both undifferentiated and differentiated neuroblastoma","volume":"6","author":"Chen","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2018.12.003_bb0145","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.27432","article-title":"Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma","volume":"131","author":"Coco","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2018.12.003_bb0150","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.2012.228","article-title":"Association of age at diagnosis and genetic mutations in patients with neuroblastoma","volume":"307","author":"Cheung","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.humpath.2018.12.003_bb0155","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000276765","article-title":"Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors","volume":"77","author":"Insabato","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.humpath.2018.12.003_bb0160","first-page":"37","article-title":"Nerve growth factor & TrkA as novel therapeutic targets in cancer","volume":"1866","author":"Demir","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.humpath.2018.12.003_bb0165","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1248\/bpb.30.638","article-title":"A novel cyclophane compound, CPPy, facilitates NGF-induced TrkA signal transduction and induces cell differentiation in neuroblastoma","volume":"30","author":"Yamaguchi","year":"2007","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.humpath.2018.12.003_bb0170","first-page":"17","article-title":"NS 1231, a novel compound with neurotrophic-like effects in vitro and in vivo","volume":"81","author":"Dago","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.humpath.2018.12.003_bb0175","doi-asserted-by":"crossref","first-page":"19461","DOI":"10.1074\/jbc.M500313200","article-title":"Human tumorous imaginal disc 1 (TID1) associates with Trk receptor tyrosine kinases and regulates neurite outgrowth in nnr5-TrkA cells","volume":"280","author":"Liu","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.humpath.2018.12.003_bb0180","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1210\/me.2009-0011","article-title":"Nucleocytoplasmic shuttling of the adapter protein SH2B1beta (SH2-Bbeta) is required for nerve growth factor (NGF)\u2013dependent neurite outgrowth and enhancement of expression of a subset of NGF-responsive genes","volume":"23","author":"Maures","year":"2009","journal-title":"Mol Endocrinol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718304969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817718304969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T01:43:20Z","timestamp":1565228600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817718304969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":36,"alternative-id":["S0046817718304969"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2018.12.003","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The presence of Y674\/Y675 phosphorylated NTRK1 via TP53 repression of PTPN6 expression as a potential prognostic marker in neuroblastoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2018.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}